NCT02548286View on ClinicalTrials.gov

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Hypertension
Interventions
DRUG

Candesartan 8mg

PO, 1day or 22day

DRUG

Amlodipine 5mg

PO, 1day or 22day

DRUG

CKD-330 8/5mg

PO, 1day or 22day

Trial Locations (1)

Unknown

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY